Glucose induces increases in levels of the transcriptional repressor Id2 via the hexosamine pathway

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 4, 2006, Pages

  Grønning, Line Mariann ^a   Tingsabadh, Rommaneeya ^a   Hardy, Kristine ^a   Dalen, Knut Thomas ^c   Jat, Parmjit S ^a   Gnudi, Luigi ^b   Shepherd, Peter R ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Atherosclerosis; Diabetes; E proteins

Indexed keywords

AZASERINE; DIMER; GLUCOSAMINE; GLUCOSE; GLUTAMINE; HEXOSAMINE; HORMONE SENSITIVE LIPASE; REPRESSOR PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTIONAL REPRESSOR ID2; UNCLASSIFIED DRUG; CHOLESTEROL ESTERASE; ENZYME INHIBITOR; GFPT1 PROTEIN, MOUSE; IDB2 PROTEIN, MOUSE; INHIBITOR OF DIFFERENTIATION 2; SREBF1 PROTEIN, MOUSE; TRANSFERASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; DRUG INHIBITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HUMAN; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; MACROPHAGE; METABOLISM; MOUSE;

ANIMALS; AZASERINE; CHOLESTEROL ESTERASE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLUCOSAMINE; GLUCOSE; GLUTAMINE; HEXOSAMINES; INHIBITOR OF DIFFERENTIATION PROTEIN 2; MACROPHAGES; MICE; NITROGENOUS GROUP TRANSFERASES; REPRESSOR PROTEINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 33646079881     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00242.2005     Document Type: Article

References (56)

1. Aoki H, Yoshimura K, Katsumura KR, Fujii K, Yamada M, and Ikeda Y. Id2 regulates post-developmental phenotype of vascular smooth muscle cells in atherosclerosis in vivo (Abstract). Circulation 108 Suppl: 109, 2003.
2. Barzilai N, Hawkins M, Angelov I, Hu M, and Rosetti L. Glucosamine induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production. Diabetes 45: 1329-1335, 1996.
3. Belletti B, Prisco M, Morrione A, Valentinis B, Navarro M, and Baserga R. Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling through by phosphatidylinositol 3-kinase. J Biol Chem 276: 13867-13874, 2001.
4. Bounpheng MA, Dimas JJ, Dodds SG, and Christy BA. Degradation of Id proteins by the ubiquitin-proteasome pathway. FASEB J 13: 2257-2264, 1999.
5. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
6. Burt DJ, Gruden G, Thomas SM, Tutt P, Dell'Anna C, Viberti GC, and Gnudi L. P38 mitigen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells. Diabetologia 46: 531-537, 2003.
7. Busch A, Cordery D, Denyer GS, and Biden TJ. Expression profiling of palmitate- and oleate-regulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic beta-cell function. Diabetes 51: 977-987, 2002.
8. Ceolotto G, Gallo A, Miola M, Sartori M, Trevisan R, Prato SD, Semplicini A, and Avogaro A. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes 48: 1316-1322, 1999.
9. Chettab K, Zibara K, Belaiba SR, and McGregor JL. Acute hyperglycaemia induces changes in the transcription levels of 4 major genes in human endothelial cells: macroarrays-based expression analysis. Thromb Haemost 87: 141-148, 2002.
10. Chou TY, Hart GW, and Dang CV. c-Myc is glycosylated at threonine-58, a known phosphorylation site and a mutational hotspot in lymphomas. J Biol Chem 270: 18961-18965, 1995.
11. Dentin R, Girard J, and Postic C. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 87: 81-86, 2005.
12. Dentin R, Pegorier J, Benhamed F, Foufelle F, Ferre P, Fauveau V, Magnuson M, Girard J, and Postic C. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem 279: 20314-20326, 2004.
13. Du X, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, and Brownlee M. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97: 12222-12226, 2000.
14. Fajerman I, Schwartz AL, and Ciechanover A. Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination. Biochem Biophys Res Commun 314: 505-512, 2004.
15. Ferre P. Regulation of gene expression by glucose. Proc Nutr Soc 58: 621-623, 1999.
16. Foretz M, Pacot C, Dugail I, Lemarchand P, Guichard C, Liepvre XL, Berthelier-Lubrano C, Spiegelman B, Kim JB, Ferre P, and Foufelle F. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol 19: 3760-3768, 1999.
17. Foufelle F and Ferre P. New perspectives in the regulation of hepatic glycolysis and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein 1c. Biochem J 366: 377-391, 2002.
18. Foufelle F, Gouhot B, Pegorier J, Perdereau D, Girard J, and Ferre P. Glucose stimulation of lipogenic enzyme gene expression in cultured white adipose tissue: a role for glucose 6-phosphate. J Biol Chem 267: 20543-20546, 1992.
19. Fukuhara-Takaki K, Sakai M, Sakamoto Y, Takeya M, and Horiuchi S. Expression of class A scavenger receptor is enhanced by high glucose in vitro and under diabetic conditions in vivo: one mechanism for an increased rate of atherosclerosis in diabetes. J Biol Chem 280: 3355-3364.
20. Goldberg HJ, Whiteside CI, and Fantus IG. The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-beta 1 and -delta. J Biol Chem 277: 33833-33841, 2002.
21. Griffin E, Re A, Hamel N, Fu C, Bush H, McAffrey T, and Asch AS. A link between diabetes and atherosclerosis: glucose regulates expression of CD36 at the level of translation. Nat Med 7: 840-846, 2001.
22. Grønning-Wang LM, Tingsabadh R, and Shepherd PR. The Id2 transcriptional repressor is induced by glucose and leptin in J774.2 macrophages. FASEB J 18: C50, 2004.
23. Hanover JA. Glycan-dependent signaling: O-linked N-acteylglucosamine. FASEB J 15: 1865-1876, 2001.
24. Hawkins M, Hu M, Yu J, Eder H, Vuguin P, She L, Barzilai N, Leiser M, Backer JM, and Rossetti L. Discordant effects of glucosamine on insulin-stimulated glucose metabolism and phosphatidylinositol 3-kinase activity. J Biol Chem 274: 31312-31319, 1999.
25. Hazel M, Cooksey RC, Jones D, Parker G, Neidigh JL, Witherbee B, Gulve EA, and McClain DA. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance. Endocrinology 145: 2118-2128, 2004.
26. Iizuka K, Bruick RK, Liang G, Horton JD, and Uyeda K. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci USA 101: 7281-7286, 2004.
27. Jonas J, Laybutt DR, Steil GM, Trivedi N, Pertusa JG, Van de Casteele M, Weir GC, and Henquin J. High glucose stimulates early response gene c-Myc expression in rat pancreatic beta-cells. J Biol Chem 276: 35375-35381, 2001.
28. Kim YB, Zhu JS, Zierath JR, Shen HQ, Baron AD, and Kahn BB. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle. Diabetes 48: 310-320, 1999.
29. Koya D and King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866, 1998.
30. Lasorella A, Noseda M, Beyna M, and Iovorone A. Id2 is a retinoblastoma protein target and mediates signaling by Myc oncoproteins. Nature 407: 592-598, 2000.
31. McClain DA. Hexosamines as mediators of nutrient sensing and regulation in diabetes. J Diabetes Complications 16: 72-80, 2002.
32. McClain DA and Crook ED. Hexosamines and insulin resistance. Diabetes 45: 1003-1009, 1996.
33. McClain DA, Lubas WA, Cooksey RC, Hazel M, Parker GJ, Love DC, and Hanover JA. Altered glycan-dependent signaling induces insulin resistance and hypeleptinemia. Proc Natl Acad Sci USA 99: 10695-10699, 2002.
34. Melnikova IN, Bounpheng M, Schatteman GC, Gilliam D, and Christy BA. Differential biological activities of mammalian Id proteins in muscle cells. Exp Cell Res 247: 94-104, 1999.
35. Moldes M, Boizard M, Le-Liepvre X, Feve B, Dugail I, and Pairault J. Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes. Biochem J 344: 873-880, 1999.
36. Moldes M, Lasnier F, Feve B, Pairault J, and Dijan P. Id3 prevents differentiation of preadipose cells. Mol Cell Biol 17: 1796-1804, 1997.
37. Neuman K, Nornes HO, and Neuman T. Helix-loop-helix transcription factors regulate Id2 gene promoter activity. FEBS Lett 374: 279-283, 1995.
38. Norton JD. Id helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 113: 3897-3905, 2000.
39. Norton JD, Deed RW, Craggs G, and Sablitzky F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol 8: 58-64, 1998.
40. O'Rourke L, Grønning LM, Yeaman SJ, and Shepherd PR. Glucose-dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin. J Biol Chem 277: 42557-42562, 2002.
41. Rossetti L. Hexosamines and nutrient sensing. Endocrinology 141: 1922-1925, 2000.
42. Sanchez HB, Yieh L, and Osborne TF. Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene. J Biol Chem 270: 1161-1169, 1995.
43. Sartippour MR, Lambert A, Laframboise M, St-Jacques P, and Renier G. Stimulatory effect of glucose on macrophage lipoprotein lipase expression and production. Diabetes 47: 431-438, 1998.
44. Schuit F, Flamez D, Vos AD, and Pipeleers D. Glucose regulated gene expression maintaining the glucose responsive state in β-cells. Diabetes 51: S326-S332, 2002.
45. Scobey MJ, Fix CA, and Walker WH. The Id2 transcriptional repressor is induced by follicle-stimulating hormone and cAMP. J of Biol Chem 279, 2004.
46. Streicher R, Kotzka J, Muller-Wieland D, Siemester G, Munck M, Avci H, and Krone W. SREBP-1 mediates activation of the low density lipoprotein receptor by insulin and insulin like growth factor-1. J Biol Chem 271: 7128-7133, 1996.
47. Talmud PJ, Palmen J, and Walker M. Identification of genetic variation in the human hormone-sensitive lipase gene and 5′ sequences. Biochem Biophys Res Commun 252: 661-668, 1998.
48. Vaulon S, Vasseur-Gognet M, and Kahn A. Glucose regulation of gene transcription. J Biol Chem 275: 31555-31558, 2000.
49. Veerababu G, Tang J, Hoffman RT, Daniels MC, Herbert LF, Crook ED, Cooksey RC, and McClain DA. Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance. Diabetes 49: 2070-2078, 2000.
50. Vicent D, Piper M, Gammeltoft S, Maratos-Flier E, and Kahn CR. Alterations in skletal muscle gene expression of ob/ob mice by mRNA differential display. Diabetes 47: 1451-1458, 1998.
51. Wang J, Liu R, Hawkins M, Barzilai N, and Rossetti L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393: 684-688, 1998.
52. Wells L, Vosseller K, and Hart GW. A role for N-acteylglucosamine as a nutrient sensor and mediator of insulin resistance. Cell Mol Life Sci 60: 222-228, 2003.
53. Wice BM, Bernal-Mizrachi E, and Permutt MA. Glucose and other insulin secretagogues induce, rather than inhibit, expression of Id-1 and Id-3 in pancreatic islet beta cells. Diabetologia 44: 453-463, 2001.
54. Yang X, Su K, Roos MD, Chang Q, Paterson AJ, and Kudlow JE. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci USA 98: 6611-6616, 2001.
55. Yokota Y, Mori S, Narumi O, and Kitajima K. In vivo function of a differentiation inhibitor, Id2. IUBMB Life 51: 207-214, 2001.
56. Zhu X, Lin Y, Zhang J, Fu M, Mao Z, and Chen YE. Thiazolidinediones, a class of anti-diabetic drugs, inhibit Id2 expression through a PPARgamma-independent pathway in human aortic smooth muscle cells. Cell Mol Life Sci 60: 212-218, 2003.